News

How Novo Nordisk Gave Up Its Weight-Loss Gains

Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.
Fierce Healthcare23m

CMMI considers weight loss drug coverage pilot as Trump IVF pledge slips: reports

The Center for Medicare and Medicaid Innovation may introduce a five-year pilot model to expand access to weight loss drugs, ...

Americans’ becoming more aware of GLP-1 drugs like Ozempic, Wegovy: Survey

The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...

“Ozempic Makeovers” on the Rise: Dr. Meegan Gruber Addresses Post-Weight-Loss Skin Laxity With Awake Body Contouring

TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...

Wegovy maker Novo hit with investor class action over revenue forecast cut

Novo Nordisk , maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish ...
Study Finds14d

Popular Weight Loss Drugs Like Ozempic May Cause Major Muscle Loss Without Boosting Fitness, Study Warns

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
3 Minute Breakdowns on MSN2d

novo nordisk stock analysis: ozempic, wegovy, and market share - august 2025

Is Novo Nordisk stock a buy? An analysis of $NVO, its weight loss drugs Ozempic and Wegovy, and market share competition with ...